MTAP is often homozygously deleted as a consequence of a passenger event, in which neighbor gene cyclin-dependent kinase inhibitor 2A (CDKN2A) is deleted, with a frequency of approximately 15% in cases of pan-cancer and exceeding 50% in certain cancer types (10, 11). Here, CDKN2A is linked to cancer.